Metabolomic Signature of Diabetic Kidney Disease in Cerebrospinal Fluid and Plasma of Patients with Type 2 Diabetes Using Liquid Chromatography-Mass Spectrometry.

Lin, Huan-Tang; Cheng, Mei-Ling; Lo, Chi-Jen; Lin, Gigin; Liu, Fu-Chao

Lin, Huan-Tang; Cheng, Mei-Ling; Lo, Chi-Jen; Lin, Gigin; Liu, Fu-Chao.

Affiliation

Lin HT; Department of Anesthesiology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Cheng ML; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Lo CJ; Metabolomics Core Laboratory, Healthy Aging Research Center, Chang Gung University, Taoyuan 333, Taiwan.
Lin G; Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
Liu FC; Clinical Metabolomics Core Laboratory, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.

Diagnostics (Basel) ; 12(11)2022 Oct 29.

Article de En | MEDLINE | ID: mdl-36359470

Mots clés

cerebrospinal fluid; diabetes mellitus; diabetic kidney disease; mass spectrometry; metabolomics

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies / Risk_factors_studies Langue: En Journal: Diagnostics (Basel) Année: 2022 Type de document: Article Pays d'affiliation: Taïwan Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google